Viewpoint

Nursing the global financial system back to health will not be the solution. Let science be the source of the green shoots of recovery, writes Nuala Moran.

Science is about to get back into Washington’s good books – and not before time, says Science|Business’s Nuala Moran.

The UK’s new £1 billion start-up fund should support entrepreneurs with immediate plans to bring a product into the market, not long-term projects to commercialise new research, says NESTA’s Sami Mahroum.

The French Presidency made headway on the Small Business Act, but other matters, notably patent reform, were run off the rails by the financial crisis, says Science|Business’s Paul Meller

Depending who you ask, the long-awaited and final ruling on the University of Wisconsin’s WARF patent is either a landmark decision or signifies nothing.

David Alcock of the Patent Attorneys D Young & Co addresses concerns that a recent patent judgment undermines the concept of evergreening, even though Tate & Lyle’s US patents to Sucralose are valid.

A new “Bretton Woods” should lead to the creation of a World Knowledge Fund with a mission to bridge the global knowledge gap.

There could be no more graphic and endearing image of the potential that stem cell research has to replace damaged or diseased tissue - and treat the previously untreatable - than the picture of the smiling, happy and restored Claudia Castillo, after a windpipe transplant.

The Future Delivery of Medicine: technology is delivering huge potential to improve treatments, but can we afford it?

More attention needs to be paid to increasing the ability of cities and regions to absorb innovation, says Sami Mahroum from the UK’s National Endowment for Science, Technology and Arts, and academic colleagues.